<DOC>
	<DOCNO>NCT02614469</DOCNO>
	<brief_summary>The purpose study assess effect food amount urate body single oral dose inosine .</brief_summary>
	<brief_title>A Food-Drug Interaction Study Serum Urate After Oral Inosine</brief_title>
	<detailed_description>Eighteen ( 18 ) eligible healthy male subject randomly assign two group 9 subject per group receive single oral dose 1000 mg inosine without food day 1 overnight fast . Subjects receive inosine food day 1 receive second dose inosine without food day 8 overnight fast . Subjects receive inosine without food day 1 overnight fast receive second dose inosine food day 8 overnight fast . Subjects admit clinic dinner day 0 7 , day dosing , stay clinic 48-h post-dose . During clinic stay , blood sample take urate measurement .</detailed_description>
	<criteria>1 . Healthy male subject age 18 65 year 2 . Bodymass index 18.0 kg/m2 32.0 kg/m2 3 . If surgically sterile , willing refrain donate sperm willing use appropriate birth control engage sexual intercourse period 90 day follow last dose study medication 4 . Serum urate &lt; 6.1 mg/dL ( approximately 360 Î¼M ) screen 5 . Nonsmokers least 6 month prior screen 6 . Adequate venous access multiple sit arm 1 . History alcohol drug dependence past 2 year 2 . Had 400 mL whole blood collection within four month 200 mL whole blood collection blood component collection within one month screen test 3 . Used prescription overthecounter ( OTC ) drug within 14 day prior screen 4 . Used vitamin preparation supplement ( include St. John 's Wort ginseng ) within 28 day prior screen test 5 . Not willing refrain alcohol , grapefruit , grapefruit juice relate product , caffeine consumption ( include chocolate ) , strenuous exercise within 72 h prior day 1 end PK study 6 . Treated investigational drug within 30 day 7 halflives investigational drug , whichever longer , prior first dose study drug 7 . Previously receive inosine supplement within three month screen subject inosine suffer adverse reaction due 8 . Known HIV disease 9 . Had febrile illness within 5 day prior first dose study medication 10 . Vaccinated within 30 day prior first dose medication 11 . Has gout history suspicion kidney stone 12 . Determined investigator subinvestigator unsuitable participate study base medical condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>